Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
First Wave BioPharma’s Pancreatic Enzyme Replacement Therapy Faces Hurdles, Stock Plummets
Source – First Wave BioPharma First Wave BioPharma, formerly known as AzurRx BioPharma, has faced ongoing challenges in bringing a ...
GSK’s Star-Studded Reunion Amplifies Meningitis Awareness Campaign
GSK has brought together Soleil Moon Frye and Melissa Joan Hart, stars of “Sabrina the Teenage Witch,” for its latest ...
Investor Lawsuit Targets Mallinckrodt for Alleged False Statements Regarding Financial Health
After Mallinckrodt Pharmaceuticals’ emergence from Chapter 11 reorganization and a $1.7 billion settlement for opioid claims, the company now faces ...
Johnson & Johnson Files Lawsuit Against Four Doctors Over Alleged Biased Opinions in Talc Defense Cases
As Johnson & Johnson (J&J) seeks ways to address its talc-related legal challenges, the company has resorted to a new ...
Lilly’s Acquisition of Versanis Aims to Enhance Patient Outcomes in Cardiometabolic Diseases
Source – Eli Lilly Eli Lilly and Versanis Bio have reached a definitive agreement for Lilly to acquire Versanis, a ...
Enhertu Receives Approval in China as Groundbreaking HER2-Directed Therapy for HER2-Low Metastatic Breast Cancer Patients
Source – AstraZeneca Enhertu (trastuzumab deruxtecan), a targeted antibody drug conjugate developed by AstraZeneca and Daiichi Sankyo, has received approval ...
FDA states that LN-145 in NSCLC is likely to receive accelerated approval
Source – Iovance Biotherapeutics The Phase II IOV-LUN-202 trial of LN-145 in patients with post-anti-PD-1 non-small cell lung cancer (NSCLC) ...
The Arrival of OTC birth control in the US
Source – FDA The US has approved the first-ever over-the-counter (OTC) contraceptive pill, providing women with a new option for ...
Roche’s Potential $7billion Acquisition: Exploring the Purchase of Roivant’s Promising Drug
According to media reports, Roche is said to be in the final stages of negotiations with Roivant for a potential ...
Funding for digital health will be at its lowest level since 2019
According to a report from Rock Health, the funding landscape in digital health is experiencing a downturn, characterized by fewer ...
In its COVID-19 vaccination lawsuits against Pfizer and BioNTech, CureVac makes further claims under the patent statute
Source – CureVac CureVac is intensifying its patent battle over COVID-19 vaccines by asserting additional claims against Pfizer and BioNTech ...
Haleon plans significant layoffs in the UK and elsewhere to save costs: report
Almost exactly one year after GSK’s consumer healthcare business spun off as Haleon, the company is reportedly implementing widespread layoffs ...
To increase treatment and adherence rates for children with HIV in low- and middle-income countries, Gilead collaborates with CHAI and Penta
Source – Gilead Sciences Gilead Sciences is pleased to announce two collaborative initiatives. The first initiative aims to expedite the ...
The first respiratory syncytial virus (RSV) vaccine for elderly people, GSK’s Arexvy, received approval from the Medicines and Healthcare Products Regulatory Agency
Source – GSK GSK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...
Zanubrutinib Plus Obinutuzumab for R/R Follicular Lymphoma Receives FDA Acceptance of sNDA
Source – BeiGene BeiGene has announced that the FDA has accepted a supplemental new drug application (sNDA) for the combination ...
Merck awards pandemic early warning system with a prize of €500,000
The annual Future Insight competition held by Germany’s Merck KGaA has awarded a €500,000 prize to Khalid Salaita, a professor ...
NHS may increase the cost of new antibiotic subscriptions
Proposals are underway to double the yearly subscription payments made by NHS England to developers of innovative antibiotics from £10 ...
Illumina was penalized €432 million for disregarding Grail merger opposition
The European Commission has imposed a significant penalty on Illumina, a leading DNA sequencing company, for finalizing its acquisition of ...
Merck increases its pressure on the IRA by requesting a ruling without a trial in its conflict with the US government
Merck is intensifying its fight against the drug price negotiation provisions in the Inflation Reduction Act (IRA) by requesting a ...
Despite a lack of essential cancer medications, the FDA approves additional chemotherapy imports from China’s Qilu Pharmaceutical
The ongoing shortage of crucial chemotherapy drugs in the United States has led the FDA to import a supply from ...
After an FDA inspection at an Indian manufacturing facility, Lupin turns off the light
Source – Lupin Lupin, a major generics company, has received a relatively mild rebuke from the US Food and Drug ...
How will Medicare be affected by the cost of Leqembi from Eisai and Biogen? Sen. Sanders is curious
Senator Bernie Sanders (I-Vt.) is increasing his pressure on the US Department of Health and Human Services (HHS) regarding the ...
Promising Phase III Results: OCREVUS (Ocrelizumab) Subcutaneous Injection Offers Convenient and Efficient Treatment for Multiple Sclerosis
Source – Roche On 13 July Roche announced positive results from the Phase III OCARINA II trial, which investigated the ...
The Safety of THIO Sequenced With Cemiplimab in NSCLC Remains Promising
Source – MAIA Biotechnology Two patients with advanced non-small cell lung cancer (NSCLC) have not experienced disease progression for 12.2 ...
Avutometinib/Defactinib Phase III Confirmatory Study in LGSOC Completes Design
Source – Verastem Oncology The FDA and Verastem Oncology have finalized the design of a Phase III clinical trial to ...
In unresectable/metastatic urothelial carcinoma, upfront nivolumab/chemotherapy prolongs survival
Source –Bristol-Myers Squibb Nivolumab plus chemotherapy showed statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival ...
VPAS negotiations are prohibited by the UK High Court from taking place
The British Generic Manufacturers Association (BGMA) has been denied a seat at the negotiation table for the new Voluntary Scheme ...
BMS purchases the Prothena Alzheimer’s medication in a $2.2 billion transaction
Source: Prothena Bristol-Myers Squibb has taken an option on a tau protein-targeting antibody in early-stage clinical development from Prothena on ...
Sensorion Seeks Approval for Clinical Trial of OTOF-GT Gene Therapy Candidate in the UK
Source – Sensorion On July 10, Sensorion filed its first regulatory application to start human testing of OTOF-GT, a gene ...
Better receives FDA approval for its primary DTx medication
Source –Better Therapeutics On 10 July, Digital health company Better Therapeutics received FDA approval for its lead digital therapeutic (DTx), ...
